公司資料
Citius Pharma 股價、新聞與催化劑
- 股票代碼:
- CTXR
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.56 USD (-25.62%)
收盤價
最後更新: 2026年8月17日
16.6M USD
市值
股價為何變動
As of Aug 17, 2026, CTXR closed down 25.6% at $0.5620. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Citius Pharma is a specialty pharmaceutical company focused on anti-infective, oncology-supportive, and hospital-related products. Its story is centered on commercializing a small number of highly specific healthcare assets.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Citius sits in specialty biopharma.
商業模式特徵
The business depends on product development, regulatory steps, and the ability to create commercial value from focused assets.
生技產業定位
Citius is a small-cap specialty-pharma name whose stock is driven by launch and regulatory milestones.
未來催化劑
- Citius’s catalysts are LYMPHIR and Mino-Lok-related updates, with the market watching whether the company can finally turn its infection-control story into something more durable. The next event that matters is the one that confirms the company still has a viable commercial path.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。